Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Evoke Pharma Inc | EVOK | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4577 | 06:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.4577 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.4004 - 2.3999 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.4577 | USD |
Evoke Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.9M | 8.48M | - | 5.18M | -7.79M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Evoke Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/17/2024 | 07:30 | GlobeNewswire Inc. | Evoke Pharma to Host Virtual Key Opinion Leader (KOL).. |
| 3/21/2024 | 15:15 | GlobeNewswire Inc. | Evoke Pharma Announces Senior Leadership Transition with.. |
| 3/14/2024 | 15:05 | GlobeNewswire Inc. | Evoke Pharma Reports Fourth Quarter and Full Year 2023.. |
| 3/07/2024 | 15:10 | GlobeNewswire Inc. | Evoke Pharma to Report Fourth Quarter and Full Year 2023.. |
| 2/23/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/20/2024 | 15:38 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/14/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 06:30 | GlobeNewswire Inc. | Evoke Pharma Announces Closing of $7.5 Million Public.. |
| 2/09/2024 | 16:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/09/2024 | 16:14 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 2/09/2024 | 06:30 | GlobeNewswire Inc. | Evoke Pharma Announces Pricing of Underwritten Public.. |
| 2/08/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EVOK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.461 | 0.55 | 0.4004 | 0.44993 | 19,669 | -0.0033 | -0.72% |
| 1 Month | 0.5826 | 0.6152 | 0.4004 | 0.4956985 | 19,750 | -0.1249 | -21.44% |
| 3 Months | 0.64 | 0.76 | 0.4004 | 0.6390088 | 41,940 | -0.1823 | -28.48% |
| 6 Months | 1.19 | 1.49 | 0.4004 | 0.7654346 | 40,179 | -0.7323 | -61.54% |
| 1 Year | 1.91 | 2.3999 | 0.4004 | 1.04 | 30,098 | -1.45 | -76.04% |
| 3 Years | 1.67 | 5.96 | 0.2261 | 1.13 | 577,685 | -1.21 | -72.59% |
| 5 Years | 0.71 | 6.0628 | 0.2261 | 1.69 | 562,937 | -0.2523 | -35.54% |
Evoke Pharma Description
| Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. |
